These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18371495)

  • 1. Can brain rhythms inform on underlying pathology in schizophrenia?
    Whittington MA
    Biol Psychiatry; 2008 Apr; 63(8):728-9. PubMed ID: 18371495
    [No Abstract]   [Full Text] [Related]  

  • 2. NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia.
    Gonzalez-Burgos G; Lewis DA
    Schizophr Bull; 2012 Sep; 38(5):950-7. PubMed ID: 22355184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schizophrenia, neurobiology and the methodology of systemic modeling.
    Tretter F; Scherer J
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S26-35. PubMed ID: 16508893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal Gamma Oscillations in N-Methyl-D-Aspartate Receptor Hypofunction Models of Schizophrenia.
    Jadi MP; Behrens MM; Sejnowski TJ
    Biol Psychiatry; 2016 May; 79(9):716-726. PubMed ID: 26281716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma oscillation deficits and the onset and early progression of schizophrenia.
    Woo TU; Spencer K; McCarley RW
    Harv Rev Psychiatry; 2010; 18(3):173-89. PubMed ID: 20415633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-methyl-D-aspartate receptor hypofunction in schizophrenia could arise from reduced cortical connectivity rather than receptor dysfunction.
    Hoffman RE; McGlashan TH
    Arch Gen Psychiatry; 1997 Jun; 54(6):578-80. PubMed ID: 9193200
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of N-Methyl-D-Aspartate Receptors in Action-Based Predictive Coding Deficits in Schizophrenia.
    Kort NS; Ford JM; Roach BJ; Gunduz-Bruce H; Krystal JH; Jaeger J; Reinhart RM; Mathalon DH
    Biol Psychiatry; 2017 Mar; 81(6):514-524. PubMed ID: 27647218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological studies of schizophrenia.
    Patterson T
    Bull Menninger Clin; 1986 May; 50(3):238-56. PubMed ID: 2873855
    [No Abstract]   [Full Text] [Related]  

  • 9. Functional brain imaging (mapping of EEG) in relation to psychopathologic changes in schizophrenia.
    Mueller T; Dierks T; Fritze J; Maurer K
    Psychiatry Res; 1989 Sep; 29(3):419-20. PubMed ID: 2608806
    [No Abstract]   [Full Text] [Related]  

  • 10. [Psychopathology in schizophrenia--disorder of neuronal connections in the cerebral cortex].
    Salokangas RK
    Duodecim; 1998; 114(14):1393-403. PubMed ID: 11552247
    [No Abstract]   [Full Text] [Related]  

  • 11. [Electrophysiologic studies].
    Bougerol T
    Encephale; 1996 Oct; 22 Spec No 3():13-7. PubMed ID: 9036004
    [No Abstract]   [Full Text] [Related]  

  • 12. FMRI indices of auditory attention in schizophrenia.
    Schirmer TN; Dorflinger JM; Marlow-O'Connor M; Pendergrass JC; Hartzell A; All SD; Charles D
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):25-32. PubMed ID: 18957312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiating cortical patterns of cognitive dysfunction in schizophrenia and posttraumatic stress disorder.
    Galletly CA; McFarlane AC; Clark R
    Psychiatry Res; 2008 May; 159(1-2):196-206. PubMed ID: 18423610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schizophrenia: signals from the other side.
    Fischbach GD
    Nat Med; 2006 Jul; 12(7):734-5. PubMed ID: 16829916
    [No Abstract]   [Full Text] [Related]  

  • 15. Stress and anxiety in schizophrenia and depression: glucocorticoids, corticotropin-releasing hormone and synapse regression.
    Bennett A O MR
    Aust N Z J Psychiatry; 2008 Dec; 42(12):995-1002. PubMed ID: 19016087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White matter abnormalities and neurocognitive deficits associated with the passivity phenomenon in schizophrenia: a diffusion tensor imaging study.
    Sim K; Yang GL; Loh D; Poon LY; Sitoh YY; Verma S; Keefe R; Collinson S; Chong SA; Heckers S; Nowinski W; Pantelis C
    Psychiatry Res; 2009 May; 172(2):121-7. PubMed ID: 19297135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycine therapy of schizophrenia: some caveats.
    Waziri R
    Biol Psychiatry; 1996 Feb; 39(3):155-6. PubMed ID: 8837976
    [No Abstract]   [Full Text] [Related]  

  • 18. Convergence of biological and psychological perspectives on cognitive coordination in schizophrenia.
    Phillips WA; Silverstein SM
    Behav Brain Sci; 2003 Feb; 26(1):65-82; discussion 82-137. PubMed ID: 14598440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent diffusion tensor imaging findings in early stages of schizophrenia.
    Kyriakopoulos M; Frangou S
    Curr Opin Psychiatry; 2009 Mar; 22(2):168-76. PubMed ID: 19553871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms underlying glutamatergic dysfunction in schizophrenia: therapeutic implications.
    Gaspar PA; Bustamante ML; Silva H; Aboitiz F
    J Neurochem; 2009 Nov; 111(4):891-900. PubMed ID: 19686383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.